Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

NORPACE®Principal Display Panel (disopyramide phosphate capsules)

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label

NDC 0025-2752-31

Pfizer

Norpace®
disopyramide phosphate
capsules USP

100 mg*

100 Capsules
Rx only

Principle Display Panel - 100 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 150 mg Capsule Bottle Label

NDC 0025-2762-31

Pfizer

Norpace®
disopyramide phosphate
capsules USP

150 mg*

100 Capsules
Rx only

Principle Display Panel - 150 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label

NDC 0025-2732-31

100 Capsules
Rx only

Norpace® CR
disopyramide phosphate
extended-release
capsules USP

100 mg*

Pfizer
Distributed by
G.D. Searle LLC
Division of Pfizer Inc, NY, NY 10017

Principle Display Panel - 100 mg Bottle Label

PRINCIPAL DISPLAY PANEL - 150 mg Bottle Label

NDC 0025-2742-31

100 Capsules
Rx only

Norpace® CR
disopyramide phosphate
extended-release
capsules USP

150 mg*

Pfizer
Distributed by
G.D. Searle LLC
Division of Pfizer Inc, NY, NY 10017

Principle Display Panel - 150 mg Bottle Label
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event